Maximizing the chances of success in rare disease development is complex. In this eBook, our biotech experts share their perspectives on what it takes to streamline every step of the rare disease drug development journey.
Rare disease drug development is complicated and rife with unique and specific challenges. Limited patient pools, geographic logistics and the unfortunate fact that many rare disease patients are children are some of the more daunting to overcome. But by selecting a development partner with specialized rare disease expertise and strong global operational capabilities, it can be done. In this eBook, Parexel Biotech shares perspectives on four ways to address challenges, including:
•
Easing trial burdens on sites
•
Ensuring pediatric trials are ethical and feasible for families
•
Speeding development with natural history studies and real-world evidence
Keeping pace with the rapidly growing biotech environment requires agility and the vision to anticipate and adapt to development challenges before they happen. Our industry-leading experts provide the experience and guidance you need to help you reach your development goals every step of the way. So you can get your innovation from the lab to the patients who need it most, faster.
This communication, induding any attachments. is intended only for the person or entity to which it is addressed and may contain confidential material. Any review, retransmission, distribution or other use of this information by persons or entities other than the intended recipient is prohibited. If you received this in error. please destroy any copies, contact the sender and delete the material from any computer. Parexel and Your Journey. Our Mission. are registered trademarks of Parexel International Corporation or its affiliates in the United States and other jurisdictions.
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact [email protected] or call 202-824-5074.
